- Home
- TVTX vs NFJ Comparison
TVTX vs NFJ Comparison
Compare TVTX & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- NFJ
- Stock Information
- Founded
- TVTX 2008
- NFJ 2005
- Country
- TVTX United States
- NFJ United States
- Employees
- TVTX N/A
- NFJ N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- NFJ Finance: Consumer Services
- Sector
- TVTX Health Care
- NFJ Finance
- Exchange
- TVTX Nasdaq
- NFJ Nasdaq
- Market Cap
- TVTX 1.3B
- NFJ 1.2B
- IPO Year
- TVTX N/A
- NFJ N/A
- Fundamental
- Price
- TVTX $17.72
- NFJ $12.87
- Analyst Decision
- TVTX Buy
- NFJ
- Analyst Count
- TVTX 13
- NFJ 0
- Target Price
- TVTX $23.46
- NFJ N/A
- AVG Volume (30 Days)
- TVTX 1.4M
- NFJ 223.5K
- Earning Date
- TVTX 10-31-2024
- NFJ 01-01-0001
- Dividend Yield
- TVTX N/A
- NFJ 9.01%
- EPS Growth
- TVTX N/A
- NFJ N/A
- EPS
- TVTX N/A
- NFJ N/A
- Revenue
- TVTX $203,447,000.00
- NFJ N/A
- Revenue This Year
- TVTX $62.45
- NFJ N/A
- Revenue Next Year
- TVTX $59.30
- NFJ N/A
- P/E Ratio
- TVTX N/A
- NFJ N/A
- Revenue Growth
- TVTX 57.08
- NFJ N/A
- 52 Week Low
- TVTX $5.12
- NFJ $10.45
- 52 Week High
- TVTX $20.33
- NFJ $12.86
- Technical
- Relative Strength Index (RSI)
- TVTX 51.53
- NFJ 50.85
- Support Level
- TVTX $16.89
- NFJ $12.57
- Resistance Level
- TVTX $19.51
- NFJ $13.08
- Average True Range (ATR)
- TVTX 1.23
- NFJ 0.12
- MACD
- TVTX -0.16
- NFJ 0.02
- Stochastic Oscillator
- TVTX 26.69
- NFJ 57.27
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often cause end-stage kidney disease.
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. Its primary investment objective is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.